Catheter Precision, Inc.
VTAK
$0.95
$0.011.26%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.31% | 6.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.31% | 6.60% | |||
| Cost of Revenue | 11.11% | 28.57% | |||
| Gross Profit | 4.81% | 5.05% | |||
| SG&A Expenses | -6.67% | 2.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.40% | 6.46% | |||
| Operating Income | 5.13% | -6.45% | |||
| Income Before Tax | -167.52% | 64.64% | |||
| Income Tax Expenses | -374.36% | 108.21% | |||
| Earnings from Continuing Operations | -149.49% | 57.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -24.73% | -73.35% | |||
| Net Income | -156.69% | 55.94% | |||
| EBIT | 5.13% | -6.45% | |||
| EBITDA | 6.18% | -7.97% | |||
| EPS Basic | -99.91% | 76.23% | |||
| Normalized Basic EPS | 258.36% | 71.46% | |||
| EPS Diluted | -99.91% | 76.23% | |||
| Normalized Diluted EPS | 258.36% | 71.46% | |||
| Average Basic Shares Outstanding | 28.40% | 85.35% | |||
| Average Diluted Shares Outstanding | 28.40% | 85.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||